Walleye Trading
SLDB icon

Walleye Trading’s Solid Biosciences SLDB Stock Holding History

Walleye Trading’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-288
Closed -$24K – 5509
2021
Q1 		$24K Buy
+288
New +$31.9K ﹤0.01% 4511
2020
Q3 		– Sell
-1,003
Closed -$44K – 4568
2020
Q2 		$44K Buy
+1,003
New +$41.6K ﹤0.01% 3826
2020
Q1 		– Sell
-1,467
Closed -$98K – 4508
2019
Q4 		$98K Buy
+1,467
New +$162K ﹤0.01% 3565
2019
Q3 		– Sell
-2,483
Closed -$214K – 4393
2019
Q2 		$214K Buy
+2,483
New +$271K ﹤0.01% 2889
2018
Q4 		– Sell
-47
Closed -$33K – 5245
2018
Q3 		$33K Buy
+47
New +$29.5K ﹤0.01% 4709

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Walleye Trading's SLDB Position: Q2 2021 in Review

Walleye Trading sold out of Solid Biosciences (SLDB) in Q2 2021, closing a stake of 288 shares — an estimated $24K sold.

Walleye Trading first reported a position in SLDB in Q3 2018 and held it in 5 quarters. The position peaked at $214K in Q2 2019. 92 funds tracked by Wall St. Rank hold SLDB as of Q2 2021.

  • Walleye Trading reported no remaining Solid Biosciences position as of Q2 2021 after selling out during the quarter.
  • Walleye Trading sold 288 Solid Biosciences shares in Q2 2021, an estimated $24K.
  • Walleye Trading first reported a position in Solid Biosciences in Q3 2018 and held it in 5 quarters.
  • Walleye Trading's Solid Biosciences position peaked at $214K in Q2 2019.
  • 92 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2021.

Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.